1-3 of 3
U. Krug, MD
Close
Sort by
Journal Articles

Comparison Of Different Pretransplant Predictive Scores In Patients With Refractory Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Including Highdose Melphalan: Results Of a Double-Center Observational Study

Nina Kristin Steckel, M.D., Markus Ditschkowski, MD, Christoph Groth, M.D., Gerda Silling, MD, U. Krug, MD, Rudolf Trenschel, MD, Hellmut Ottinger, MD, Wolfgang E Berdel, MD, Michael Koldehoff, MD, Ahmet H. Elmaagacli, Dietrich Beelen, MD, Matthias Stelljes, MD
Journal: Blood
Blood (2013) 122 (21): 4525.
https://doi.org/10.1182/blood.V122.21.4525.4525
Published: 2013
Journal Articles

Factors Influencing Complete Remission (CR) Rate in Patients ≥ 60 Years with Acute Myeloid Leukemia (AML): Report From the German AML Intergroup Study

Dietger Niederwieser, Verena S Hoffmann, MA., Rainer Krahl, MD, Wolfgang E. Berdel, MD, Maria Cristina Sauerland, Wolfgang Hiddemann, MD, PhD, Ute Hegenbart, MD, Bernhard Josef Woermann, MD, U. Krug, MD, Wolfram Pönisch, Vladan Vucinic, Karin Hebenstreit, Michael Cross, PhD, Christian Niederwieser, Markus Pfirrmann, A Schulze, Alwin Kraemer, Georg Maschmeyer, Mathias Freund, MD, S Scholl, Thomas Heinicke, D Haehling, Hans-Heinrich Wolf, MD, Thomas Büchner, MD
Journal: Blood
Blood (2012) 120 (21): 128.
https://doi.org/10.1182/blood.V120.21.128.128
Published: 2012
Journal Articles

A Multicentre Phase II Study of the Aminopeptidase Inhibitor, CHR- 2797, in the Treatment of Elderly and/or Previously Treated patients with Acute Myeloid Leukemia.

B. Lowenberg, MD, F. Davies, MD, C. Müller-Tidow, MD, Ulrich Dührsen, A. Burnett, MD, FRCP, P. Zachée, MD, PhD, D. Dierickx, MD, C. Jenkins, MD, P. Sonneveld, MD, M. Jongen-Lavrencic, MD, S. Zweegman, MD, G. Morgan, MD, U. Krug, MD, A. Richardson, PhD, L. Hooftman, MD, G. Ossenkoppele, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 961.
https://doi.org/10.1182/blood.V112.11.961.961
Published: 2008